Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management...